Small Study Tests Colchicine for Moderate-to-Severe COVID-19

FRIDAY, Feb. 5, 2021 -- For patients with moderate-to-severe COVID-19, colchicine reduces the length of supplemental oxygen therapy and hospitalization, according to a study published online Feb. 4 in RMD Open. Maria Isabel Lopes, from the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news